Literature DB >> 2497730

Glucagon desensitization of adenylate cyclase and stimulation of inositol phospholipid metabolism does not involve the inhibitory guanine nucleotide regulatory protein Gi, which is inactivated upon challenge of hepatocytes with glucagon.

G J Murphy1, D J Gawler, G Milligan, M J Wakelam, N J Pyne, M D Houslay.   

Abstract

Brief exposure of hepatocytes to glucagon, angiotensin or the protein kinase C activator TPA (12-O-tetradecanoylphorbol 13-acetate) caused the inactivation of the inhibitory guanine nucleotide regulatory protein Gi. Glucagon-mediated desensitization of glucagon-stimulated adenylate cyclase activity was seen in hepatocytes from both normal rats and those made diabetic with streptozotocin, where Gi is not functionally expressed. Normal glucagon desensitization was seen in hepatocytes from young animals, 6 weeks of age, which had amounts of Gi in their hepatocyte membranes which were some 45% of that seen in mature animals (3.4 pmol/mg of plasma-membrane protein). Streptozotocin-induced diabetes in young animals abolished the appearance of functional Gi in hepatocyte plasma membranes. Pertussis-toxin treatment of hepatocytes from both normal mature animals and those made diabetic, with streptozotocin, blocked the ability of glucagon or angiotensin or TPA to elicit desensitization of adenylate cyclase. The isolated B (binding)-subunit of pertussis toxin was ineffective in blocking desensitization. Neither induction of diabetes nor treatment of hepatocytes with pertussis toxin inhibited the ability of glucagon and angiotensin to stimulate the production of inositol phosphates in intact hepatocytes. Thus (i) Gi does not appear to play a role in the molecular mechanism of glucagon desensitization in hepatocytes, (ii) the G-protein concerned with receptor-stimulated inositol phospholipid metabolism in hepatocytes appears not to be a substrate for the action of pertussis toxin, (iii) in intact hepatocytes, treatment with glucagon and/or angiotensin can elicit the inactivation of the inhibitory G-protein Gi, and (iv) pertussis toxin blocks desensitization by a process which does not involve Gi.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2497730      PMCID: PMC1138490          DOI: 10.1042/bj2590191

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  36 in total

1.  Use of the liquid scintillation spectrometer for determining adenosine triphosphate by the luciferase enzyme.

Authors:  P E Stanley; S G Williams
Journal:  Anal Biochem       Date:  1969-06       Impact factor: 3.365

2.  Purification and properties of the insulin-stimulated cyclic AMP phosphodiesterase from rat liver plasma membranes.

Authors:  R J Marchmont; S R Ayad; M D Houslay
Journal:  Biochem J       Date:  1981-06-01       Impact factor: 3.857

3.  Cholera toxin mediated activation of adenylate cyclase in intact rat hepatocytes.

Authors:  M D Houslay; K R Elliott
Journal:  FEBS Lett       Date:  1979-08-15       Impact factor: 4.124

4.  A simplification of the protein assay method of Lowry et al. which is more generally applicable.

Authors:  G L Peterson
Journal:  Anal Biochem       Date:  1977-12       Impact factor: 3.365

5.  Multiple defects occur in the guanine nucleotide regulatory protein system in liver plasma membranes of obese (fa/fa) but not lean (Fa/Fa) Zucker rats: loss of functional Gi and abnormal Gs function.

Authors:  M D Houslay; D J Gawler; G Milligan; A Wilson
Journal:  Cell Signal       Date:  1989       Impact factor: 4.315

6.  Differential effects of tryptophan on glucose synthesis in rats and guinea pigs.

Authors:  S A Smith; K R Elliott; C I Pogson
Journal:  Biochem J       Date:  1978-12-15       Impact factor: 3.857

7.  Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands.

Authors:  M J Berridge; C P Downes; M R Hanley
Journal:  Biochem J       Date:  1982-09-15       Impact factor: 3.857

8.  A role of the B-oligomer moiety of islet-activating protein, pertussis toxin, in development of the biological effects on intact cells.

Authors:  M Tamura; K Nogimori; M Yajima; K Ase; M Ui
Journal:  J Biol Chem       Date:  1983-06-10       Impact factor: 5.157

9.  Guanine nucleotide inhibition of cyc- S49 mouse lymphoma cell membrane adenylyl cyclase.

Authors:  J D Hildebrandt; J Hanoune; L Birnbaumer
Journal:  J Biol Chem       Date:  1982-12-25       Impact factor: 5.157

10.  Forskolin and ethanol both perturb the structure of liver plasma membranes and activate adenylate cyclase activity.

Authors:  A D Whetton; L Needham; N J Dodd; C M Heyworth; M D Houslay
Journal:  Biochem Pharmacol       Date:  1983-05-15       Impact factor: 5.858

View more
  5 in total

1.  Phosphorylation of the spliced variant forms of the recombinant stimulatory guanine-nucleotide-binding regulatory protein (Gs alpha) by protein kinase C.

Authors:  N J Pyne; M Freissmuth; S Palmer
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

2.  Glucagon, vasopressin and angiotensin all elicit a rapid, transient increase in hepatocyte protein kinase C activity.

Authors:  E K Tang; M D Houslay
Journal:  Biochem J       Date:  1992-04-15       Impact factor: 3.857

3.  Hormonal regulation of Gi2 alpha-subunit phosphorylation in intact hepatocytes.

Authors:  M Bushfield; G J Murphy; B E Lavan; P J Parker; V J Hruby; G Milligan; M D Houslay
Journal:  Biochem J       Date:  1990-06-01       Impact factor: 3.857

4.  High-fat diet-induced hepatic steatosis reduces glucagon receptor content in rat hepatocytes: potential interaction with acute exercise.

Authors:  Alexandre Charbonneau; Cecilia G Unson; Jean-Marc Lavoie
Journal:  J Physiol       Date:  2006-10-19       Impact factor: 5.182

5.  Conditions that result in the mobilization and influx of Ca2+ into rat hepatocytes induce the rapid loss of 3-hydroxy-3-methylglutaryl-CoA reductase activity that is not reversed by phosphatase treatment.

Authors:  V A Zammit; A M Caldwell
Journal:  Biochem J       Date:  1990-07-15       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.